May/June 2013
Biopharma Asia
May/June 2013 | Volume 2 Issue 3
Oral Multiparticulates as a Flexible Solid Dosage Form Approach for Paediatric Use
By: Anne Cram , Senior Principal Scientist; Jeremy A. Bartlett , Associate Research ...
Enhancing the Solubility of Poorly Soluble Drug Substances
By: Harry G. Brittain, Institute Director Center for Pharmaceutical Physics
The Global Fight Against Falsified and Substandard Medicines
By: Tom Woods, CEO Woods International LLC
An Introduction to Rapid Microbiological Methods: Regulatory Acceptance, Validation and Im...
By: Michael Miller, President of Microbiology Consultants LLC
Considerations in the Technology Transfer and Scale up of Lyophilised Products
By: Tim McCoy, Principal Scientist; Matthew Brown, Development Scientist; Martin Addo...
Implementation of Single-Use Bioreactors for Viral Vaccines Process Development
By: Ludovic Peeters, Scientist - New Technologies; Jean-François Chaubard, Director of...
Phase III/Post-Commercialisation Changes: Extractable and Leachables Considerations for Co...
By: Ken Wong, Senior Scientist, Center for Extractables and Leachables Merck & Co.,...
Addressing Material Properties in the Design of a Direct Compression Continuous Manufactur...
By: Fernando Muzzio, Professor; Sarang Oka, Graduate; William Engisch, Graduate Rutg...
















